Dawn M. Wahezi

1.1k total citations
36 papers, 379 citations indexed

About

Dawn M. Wahezi is a scholar working on Epidemiology, Hematology and Rheumatology. According to data from OpenAlex, Dawn M. Wahezi has authored 36 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Hematology and 10 papers in Rheumatology. Recurrent topics in Dawn M. Wahezi's work include Inflammatory Myopathies and Dermatomyositis (12 papers), Autoimmune and Inflammatory Disorders Research (11 papers) and Systemic Lupus Erythematosus Research (7 papers). Dawn M. Wahezi is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (12 papers), Autoimmune and Inflammatory Disorders Research (11 papers) and Systemic Lupus Erythematosus Research (7 papers). Dawn M. Wahezi collaborates with scholars based in United States, Canada and United Kingdom. Dawn M. Wahezi's co-authors include Norman T. Ilowite, Tamar B. Rubinstein, Chaim Putterman, Ann M. Reed, Adam M. Huber, Brian M. Feldman, Mara L. Becker, Elizabeth A. Kessler, Heinrike Schmeling and Mark F. Hoeltzel and has published in prestigious journals such as The Journal of Immunology, PEDIATRICS and The Journal of Pediatrics.

In The Last Decade

Dawn M. Wahezi

32 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn M. Wahezi United States 12 178 114 78 73 58 36 379
Kátia Tomie Kozu Brazil 11 196 1.1× 55 0.5× 80 1.0× 73 1.0× 34 0.6× 40 330
Cássia Maria Passarelli Lupoli Barbosa Brazil 14 234 1.3× 63 0.6× 100 1.3× 111 1.5× 37 0.6× 28 434
Euan McRorie United Kingdom 10 175 1.0× 97 0.9× 56 0.7× 80 1.1× 89 1.5× 22 429
J.L. Dupond France 12 108 0.6× 116 1.0× 48 0.6× 45 0.6× 60 1.0× 52 455
Ediz Dalkılıç Türkiye 11 224 1.3× 35 0.3× 148 1.9× 84 1.2× 42 0.7× 72 494
Chengappa Kavadichanda India 13 231 1.3× 64 0.6× 112 1.4× 80 1.1× 46 0.8× 62 521
G. Guettrot-Imbert France 11 377 2.1× 36 0.3× 135 1.7× 63 0.9× 46 0.8× 35 536
I C Abbs United Kingdom 13 181 1.0× 51 0.4× 139 1.8× 112 1.5× 39 0.7× 27 511
Teresa Cristina Martins Vicente Robazzi Brazil 11 111 0.6× 21 0.2× 87 1.1× 68 0.9× 47 0.8× 27 298
Jenaro Graña Gil Spain 10 115 0.6× 36 0.3× 33 0.4× 84 1.2× 65 1.1× 29 394

Countries citing papers authored by Dawn M. Wahezi

Since Specialization
Citations

This map shows the geographic impact of Dawn M. Wahezi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn M. Wahezi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn M. Wahezi more than expected).

Fields of papers citing papers by Dawn M. Wahezi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn M. Wahezi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn M. Wahezi. The network helps show where Dawn M. Wahezi may publish in the future.

Co-authorship network of co-authors of Dawn M. Wahezi

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn M. Wahezi. A scholar is included among the top collaborators of Dawn M. Wahezi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn M. Wahezi. Dawn M. Wahezi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rouster‐Stevens, Kelly, Amanda Robinson, Delaney D Ding, et al.. (2025). Imaging assessment of calcinosis in juvenile dermatomyositis: a narrative review. Pediatric Rheumatology. 23(1). 44–44.
3.
Brunner, Hermine I., Esraa M. Eloseily, Yonatan Butbul Aviel, et al.. (2024). Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis. Arthritis Care & Research. 76(12). 1723–1732. 1 indexed citations
4.
Wahezi, Dawn M., et al.. (2023). Impact of SARS-CoV-2 on the clinical presentation of juvenile idiopathic inflammatory myopathies. Pediatric Rheumatology. 21(1). 82–82. 1 indexed citations
5.
Hoffman, Alicia, et al.. (2022). Storytelling of Young Adults with Chronic Rheumatologic Illnesses: A Pilot Study. Healthcare. 10(10). 1979–1979. 5 indexed citations
6.
Ramesh, Manish, Denisa Ferastraoaru, Golda Hudes, et al.. (2021). Rapid Implementation of a Multidisciplinary COVID‐19 Cytokine Storm Syndrome Task Force. ACR Open Rheumatology. 3(3). 133–137. 1 indexed citations
7.
Wahezi, Dawn M., et al.. (2021). Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies. Pediatric Rheumatology. 19(1). 92–92. 9 indexed citations
8.
Wahezi, Dawn M., et al.. (2020). Association of Medication Access Difficulty and COVID‐19–Related Distress With Disease Flares in Rheumatology Patients During the COVID‐19 Pandemic. Arthritis Care & Research. 73(8). 1162–1170. 19 indexed citations
10.
Liu, Kuan, George Tomlinson, Ann M. Reed, et al.. (2020). Pilot Study of the Juvenile Dermatomyositis Consensus Treatment Plans: A CARRA Registry Study. The Journal of Rheumatology. 48(1). 114–122. 13 indexed citations
11.
Wahezi, Dawn M., et al.. (2020). Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19. Paediatric Respiratory Reviews. 35. 81–87. 20 indexed citations
12.
Smith, Eve, Antonio Eleuteri, Béatrice Goilav, et al.. (2018). A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity. Clinical Immunology. 198. 71–78. 11 indexed citations
13.
Zikánová, Marie, Dawn M. Wahezi, Blanka Stibůrková, et al.. (2018). Clinical manifestations and molecular aspects of phosphoribosylpyrophosphate synthetase superactivity in females. Lara D. Veeken. 57(7). 1180–1185. 15 indexed citations
14.
Rubinstein, Tamar B., Wenzhu Mowrey, Norman T. Ilowite, & Dawn M. Wahezi. (2017). Delays to Care in Pediatric Lupus Patients: Data From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Arthritis Care & Research. 70(3). 420–427. 25 indexed citations
15.
Berko, Netanel S., et al.. (2015). Efficacy of ultrasound elastography in detecting active myositis in children: can it replace MRI?. Pediatric Radiology. 45(10). 1522–1528. 17 indexed citations
16.
Wahezi, Dawn M. & Norman T. Ilowite. (2013). Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives. Expert Opinion on Pharmacotherapy. 14(8). 975–989. 8 indexed citations
17.
Wahezi, Dawn M., et al.. (2012). Giant coronary artery aneurysms in juvenile polyarteritis nodosa: a case report. Pediatric Rheumatology. 10(1). 1–1. 12 indexed citations
18.
Wahezi, Dawn M., et al.. (2011). Chronic Leg Ulceration as the Presenting Feature of Diffuse Systemic Sclerosis in Childhood. The Journal of Pediatrics. 159(4). 698–698. 4 indexed citations
19.
Janow, Ginger, Norman T. Ilowite, & Dawn M. Wahezi. (2011). Wasabi nose: an underreported complication of cyclophosphamide infusions. Clinical Rheumatology. 30(7). 1003–1005. 1 indexed citations
20.
Wahezi, Dawn M., William A. Gomes, & Norman T. Ilowite. (2010). Cranial Nerve Involvement With Juvenile Polyarteritis Nodosa: Clinical Manifestations and Treatment. PEDIATRICS. 126(3). e719–e722. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026